Advanced Cell Technology, Inc.
A biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California, and Worcester, Massachusetts.
site: http://www.advancedcell.com |
Single-Cell Embryo Biopsy
Single-Blastomere-Biopsied Embryos -- reduce or eliminate ethical concerns
ACT site: http://www.advancedcell.com |
July 20, 2006
Advanced Cell Technology Applauds Governor Schwarzenegger for Directing $150 Million Loan to Fund Stem Cell Research; Further Positions California as World Leader in Field of Regenerative Medicine
William M. Caldwell, IV, Chief
Executive Officer of Advanced Cell Technology, Inc.
today praised Governor Schwarzenegger
for directing the state to issue a loan of up to $150 million to the California
Institute of Regenerative Medicine (CIRM). CIRM is the state agency responsible
for disbursing $3 billion for stem cell research to California universities
and research institutions. "Governor Schwarzenegger has further positioned
California to lead the nation in the promising field of regenerative medicine,"
said Mr. Caldwell. "I believe we are now one step closer to developing
therapies for devastating diseases and injuries such as heart disease,
cancer, macular degeneration, Parkinson's, Alzheimer's, and diabetes, as
we anticipate that this funding will provide CIRM the opportunity to move
quickly into a major program of research in California."
Earlier this year, Advanced Cell
Technology
moved its headquarters and opened
a state-of-the-art R&D facility in California,capable laboratory.
which encompasses a 10,000-square-foot
Good Manufacturing Practice (GMP)
"We stand ready to partner with
institutions in California to help move the science forward, and ultimately
work toward translation from the laboratory to productization -- new treatments
for debilitating and deadly diseases," said Mr. Caldwell. "We are completely
focused on driving our key therapeutic programs into the clinic, and believe
we will be among the first to treat patients with hESC-derived cell therapies."
Advanced Cell Technology
-- hESC-derived
cell therapies | text
|
-- California Stem
Cell Research |
Advanced Cell Technology
Robert Lanza, M.D., Vice President
of Research & Scientific Development,
and his colleagues continue
to receive favorable reviews for
Essentials of Stem Cell Biology | Amazon Books |the recently-released landmark volume on embryonic and adult stem cell research and its real-world applications. Dr. Lanza served as Editor-in-Chief, and co-edited the volume with several other leading experts in the area of stem cell research and regenerative medicine.
Highly praised in Nature Cell Biology, the book received critical accolades from the prestigious New England Journal of Medicine in their June 29, 2006 issue when, Gosta Gahrton, M.D., Ph.D., of the Karolinska Institute, Stockholm, Sweden, wrote: "Essentials of Stem Cell Biology belongs on the shelf of every researcher, clinician, and student who is interested in new developments in stem-cell research and the related treatment options that are being developed."
Additionally, in a five star, 100 out of 100-point review in Doody's Book Review, the premiere book review service for more than a million healthcare professionals, Bruce A. Fenderson, Ph.D., of Thomas Jefferson University wrote: "This beautiful hardcover book provides a concise and complete introduction to the theory and practice of stem cell research... This is the best book I've reviewed on stem cell biology. Comprehensive, yet concise... This is the one book to have for anyone interested in the promise of stem cell research... it will provide an excellent resource for years to come."
Essentials of Stem Cell Biology is an abridged version of the bestselling reference, Handbook of Stem Cells, a two-volume set. The new work incorporates all the essential subject matter of the original two-volume edition into a single volume. The material in the first set has been reworked in a more-accessible format suitable for both students and general readers interested in the latest advances in stem cells, and includes numerous full-color presentations. The new format is designed to promote better understanding of the scientific and ethical issues involved with adult and embryonic stem cell research and associated real-life applications.
Essentials of Stem Cell Biology was co-edited by thought leaders John Gearhart, Johns Hopkins University School of Medicine, Baltimore, Maryland; Brigid Hogan, Duke University Medical Center, Durham, North Carolina; Douglas Melton, Howard Hughes Medical Institute, Harvard University, Cambridge, Massachusetts; Roger Pedersen, Department of Surgery, University of Cambridge and Addenbrooke's Hospital, Cambridge, U.K.; James Thomson, Wisconsin Regional Primate Research Center, University of Wisconsin, Madison, Wisconsin; E. Donnall Thomas, Director Emeritus, Fred Hutchinson Cancer Research Center, Seattle, Washington; and Michael West, Chairman, President and Chief Scientific Officer, Advanced Cell Technology.
"At a time when harnessing the promise of stem cell therapies and bringing them to the bedside looks increasingly viable, here at ACT and at other companies and research institutions, Dr. Lanza's treatise has emerged as one that an increasing number of scientists and non-scientists alike are relying upon as an indispensable guide to understanding stem cell biology," said William Caldwell, CEO of Advanced Cell Technology.